Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2024

Personalising gastrointestinal (GI) oncology: From old to new target inhibition

Targeted options in patients with RAS or BRAF mutant tumours: Not only a colorectal cancer matter

Date

07 Dec 2024

Session

Personalising gastrointestinal (GI) oncology: From old to new target inhibition

Topics

Tumour Site

Hepatobiliary Cancers;  Pancreatic Adenocarcinoma;  Colon and Rectal Cancer

Presenters

Dominik Modest

Authors

D.P. Modest

Author affiliations

  • Medicine Department Of Hematology, Oncology And Tumorimmunology, Charité - Universitaetsmedizin Berlin, 13353 - Berlin/DE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Session: Personalising gastrointestinal (GI) oncology: From old to new target inhibition

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.